home / stock / edit / edit news

EDIT News and Press, Editas Medicine Inc. From 09/29/23

Stock Information
Company Name: Editas Medicine Inc.
Stock Symbol: EDIT
Market: NASDAQ
Website: editasmedicine.com
Menu
EDIT EDIT Quote EDIT Short EDIT News EDIT Articles EDIT Message Board
Get EDIT Alerts

News, Short Squeeze, Breakout and More Instantly...
EDIT - Editas gains as Stifel upgrades on sickle cell disease potential

2023-09-29 07:49:11 ET More on Editas Editas Medicine, Inc. (EDIT) Cantor Global Healthcare Conference 2023 - (Transcript) Editas Medicine, Inc. (EDIT) CEO Gilmore O'Neill Presents at Morgan Stanley 21st Annual Global Healthcare Conference (Transcript) Editas Medicin...
EDIT - Biggest stock movers today: Nike, Editas Medicine and more

2023-09-29 05:36:01 ET Related stories: NIKE, Inc. (NKE) Q1 2024 Earnings Call Transcript Nike in charts: Q1 footwear revenue climbs from last year, but dips from Q4 Nike Earnings Preview: Low Expectations With Poor Sentiment; Comps Get Easier In FY '24 Edita...

EDIT - MQ, BIOR and ACRS are among after hour movers

2023-09-28 17:12:16 ET Gainers: Editas Medicine ( NASDAQ: EDIT ) +8% . Marqeta ( MQ ) +3% . Cipher Mining ( CIFR ) +3% . Aclaris Therapeutics ( ACRS ) +2% . Biora Therapeutics ( BIOR ) +2% . Losers: Jaguar Global Grow...

EDIT - Editas Medicine, Inc. (EDIT) Cantor Global Healthcare Conference 2023 - (Transcript)

2023-09-26 16:45:02 ET Editas Medicine, Inc. (EDIT) Cantor Global Healthcare Conference 2023 Call September 26, 2023, 01:35 PM ET Company Participants Baisong Mei - Senior Vice President and Chief Medical Officer Erick Lucera - Executive Vice President and Chief Fina...
EDIT - Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the grant of an inducement award to the Company’s newly appointed Chief Commercial and Strategy Officer, Caren Deardorf. In connecti...

EDIT - Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the appointment of Caren Deardorf as the Company’s first Chief Commercial and Strategy Officer. Ms. Deardorf will build and lead Editas Medici...

EDIT - Editas Medicine, Inc. (EDIT) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)

2023-09-11 13:26:03 ET Editas Medicine, Inc. (EDIT) Morgan Stanley 21st Annual Global Healthcare Conference Call September 11, 2023 10:00 AM ET Company Participants Gilmore O’Neill - President and Chief Executive Officer Baisong Mei - Senior Vice President and...
EDIT - Editas Medicine, Inc. (EDIT) Presents at Wells Fargo Securities Healthcare Conference Call Transcript

2023-09-07 19:11:10 ET Editas Medicine, Inc. (EDIT) Wells Fargo Securities Healthcare Conference Call September 7, 2023, 15:00 PM ET Company Participants Gilmore O'Neill - President and Chief Executive Officer Baisong Mei - Senior Vice President and Chief Medical Off...

EDIT - Editas Medicine Announces Upcoming Investor Events

CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that management will participate in the following upcoming investor conferences: 2023 Wells Fargo Healthcare Conference Format: Fireside...

EDIT - Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer

Jeff Caravella brings over two decades of healthcare expertise steering strategic, financial and operational functions at leading public life-science corporations Mr. Caravella’s appointment demonstrates Medicenna’s continuing commitment to establish its presence in Boston, ...
Previous 10 Next 10